JK
Jayaprakash Kanijam Raghupathi
Cardinal Health (United States), Purdue University West Lafayette, Acharya Nagarjuna University
0009-0005-7313-6472
Employment
-
Cardinal Health (United States) Scientist III ( Sr Scientist III)2025 - Present
Education
-
Purdue University West Lafayette Visiting Scholar2023 - Present
-
Acharya Nagarjuna University Doctor of Philosophy (Analytical Chemistry)2023 - Present
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant Identification Save
- Characterization and Analytical Method Validation for Potential Impurities of a Merchantability Drug Substance Fluoxetine HCl Save
- Acid Degradation Study of Dapagliflozin: Structural Characterization of Dapagliflozin and its Degradation Products Using Advanced Analytical Techniques and In Silico Toxicity Prediction Save
- Combination of Ethylene glycol and TBAB-mediated pyrimidine fused heterocyclic derivatives: Synthesis, in silico, and in vitro anti-diabetic and anti-microbial studies Save
- Design, Synthesis, and Biological Evaluation of Novel Heterocyclic Derivatives of 2,4-Thiazolidine Dione as Anti-Cancer Agents Save
- Development of LC/LCMS method for estimation of impurities in anti-HIV drug (Bictegravir) using Analytical Quality by Design (AQbD) approach Save
- Human-associated gut bacterial dysbiosis affects the anti-colitic activity of 3-DF and 3-HF Save
- Pyrimidine fused heterocyclic derivatives: Design, in silico, in vitro, anti-microbial, antidiabetic and anti-biofilm studies Save
- Utilizing quality by design methodology for liquid chromatography method development and validation in quantifying impurities in Pitolisant, a Histamine-3 (H3) receptor antagonist/inverse agonist Save
- Composition of Human-Associated Gut Microbiota Determines 3-DF and 3-HF Anti-Colitic Activity in IL-10 -/- Mice Save